-
1 Comment
Japan Lifeline Co., Ltd is currently in a long term downtrend where the price is trading 5.6% below its 200 day moving average.
From a valuation standpoint, the stock is 96.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Japan Lifeline Co., Ltd's total revenue rose by 0.2% to $14B since the same quarter in the previous year.
Its net income has dropped by 215.2% to $-3B since the same quarter in the previous year.
Based on the above factors, Japan Lifeline Co., Ltd gets an overall score of 2/5.
Exchange | TSE |
---|---|
CurrencyCode | JPY |
ISIN | JP3754500001 |
Sector | Healthcare |
Industry | Medical Devices |
Beta | 0.19 |
---|---|
Market Cap | 108B |
PE Ratio | 15.62 |
Target Price | 1726 |
Dividend Yield | 6.1% |
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems; and coronary and peripheral intervention products include PTCA and PTA guide wires, and PTCA balloon catheters. In addition, the company offers gastrointestinal intervention products that cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and neurovascular intervention products. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7575.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025